1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Psoriasis Treatment Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 TNF Inhibitors
1.2.3 Interleukin Inhibitors
1.2.4 Vitamin D Analogs
1.2.5 Corticosteroids
1.2.6 Others
1.3 Market by Application
1.3.1 Global Psoriasis Treatment Drugs Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Oral
1.3.3 Parenteral
1.3.4 Topical
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Psoriasis Treatment Drugs Market Perspective (2017-2028)
2.2 Psoriasis Treatment Drugs Growth Trends by Region
2.2.1 Psoriasis Treatment Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Psoriasis Treatment Drugs Historic Market Size by Region (2017-2022)
2.2.3 Psoriasis Treatment Drugs Forecasted Market Size by Region (2023-2028)
2.3 Psoriasis Treatment Drugs Market Dynamics
2.3.1 Psoriasis Treatment Drugs Industry Trends
2.3.2 Psoriasis Treatment Drugs Market Drivers
2.3.3 Psoriasis Treatment Drugs Market Challenges
2.3.4 Psoriasis Treatment Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Psoriasis Treatment Drugs Players by Revenue
3.1.1 Global Top Psoriasis Treatment Drugs Players by Revenue (2017-2022)
3.1.2 Global Psoriasis Treatment Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Psoriasis Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Psoriasis Treatment Drugs Revenue
3.4 Global Psoriasis Treatment Drugs Market Concentration Ratio
3.4.1 Global Psoriasis Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Psoriasis Treatment Drugs Revenue in 2021
3.5 Psoriasis Treatment Drugs Key Players Head office and Area Served
3.6 Key Players Psoriasis Treatment Drugs Product Solution and Service
3.7 Date of Enter into Psoriasis Treatment Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Psoriasis Treatment Drugs Breakdown Data by Type
4.1 Global Psoriasis Treatment Drugs Historic Market Size by Type (2017-2022)
4.2 Global Psoriasis Treatment Drugs Forecasted Market Size by Type (2023-2028)
5 Psoriasis Treatment Drugs Breakdown Data by Application
5.1 Global Psoriasis Treatment Drugs Historic Market Size by Application (2017-2022)
5.2 Global Psoriasis Treatment Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Psoriasis Treatment Drugs Market Size (2017-2028)
6.2 North America Psoriasis Treatment Drugs Market Size by Country (2017-2022)
6.3 North America Psoriasis Treatment Drugs Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Psoriasis Treatment Drugs Market Size (2017-2028)
7.2 Europe Psoriasis Treatment Drugs Market Size by Country (2017-2022)
7.3 Europe Psoriasis Treatment Drugs Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Psoriasis Treatment Drugs Market Size (2017-2028)
8.2 Asia-Pacific Psoriasis Treatment Drugs Market Size by Country (2017-2022)
8.3 Asia-Pacific Psoriasis Treatment Drugs Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Psoriasis Treatment Drugs Market Size (2017-2028)
9.2 Latin America Psoriasis Treatment Drugs Market Size by Country (2017-2022)
9.3 Latin America Psoriasis Treatment Drugs Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Psoriasis Treatment Drugs Market Size (2017-2028)
10.2 Middle East & Africa Psoriasis Treatment Drugs Market Size by Country (2017-2022)
10.3 Middle East & Africa Psoriasis Treatment Drugs Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Psoriasis Treatment Drugs Introduction
11.1.4 Amgen Revenue in Psoriasis Treatment Drugs Business (2017-2022)
11.1.5 Amgen Recent Development
11.2 Allergan
11.2.1 Allergan Company Detail
11.2.2 Allergan Business Overview
11.2.3 Allergan Psoriasis Treatment Drugs Introduction
11.2.4 Allergan Revenue in Psoriasis Treatment Drugs Business (2017-2022)
11.2.5 Allergan Recent Development
11.3 Dermira
11.3.1 Dermira Company Detail
11.3.2 Dermira Business Overview
11.3.3 Dermira Psoriasis Treatment Drugs Introduction
11.3.4 Dermira Revenue in Psoriasis Treatment Drugs Business (2017-2022)
11.3.5 Dermira Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Detail
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Psoriasis Treatment Drugs Introduction
11.4.4 Eli Lilly Revenue in Psoriasis Treatment Drugs Business (2017-2022)
11.4.5 Eli Lilly Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Psoriasis Treatment Drugs Introduction
11.5.4 Novartis Revenue in Psoriasis Treatment Drugs Business (2017-2022)
11.5.5 Novartis Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Psoriasis Treatment Drugs Introduction
11.6.4 Merck Revenue in Psoriasis Treatment Drugs Business (2017-2022)
11.6.5 Merck Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Detail
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Psoriasis Treatment Drugs Introduction
11.7.4 Johnson & Johnson Revenue in Psoriasis Treatment Drugs Business (2017-2022)
11.7.5 Johnson & Johnson Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Detail
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Psoriasis Treatment Drugs Introduction
11.8.4 Pfizer Revenue in Psoriasis Treatment Drugs Business (2017-2022)
11.8.5 Pfizer Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Detail
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Psoriasis Treatment Drugs Introduction
11.9.4 AstraZeneca Revenue in Psoriasis Treatment Drugs Business (2017-2022)
11.9.5 AstraZeneca Recent Development
11.10 AbbVie
11.10.1 AbbVie Company Detail
11.10.2 AbbVie Business Overview
11.10.3 AbbVie Psoriasis Treatment Drugs Introduction
11.10.4 AbbVie Revenue in Psoriasis Treatment Drugs Business (2017-2022)
11.10.5 AbbVie Recent Development
11.11 LEO Pharma
11.11.1 LEO Pharma Company Detail
11.11.2 LEO Pharma Business Overview
11.11.3 LEO Pharma Psoriasis Treatment Drugs Introduction
11.11.4 LEO Pharma Revenue in Psoriasis Treatment Drugs Business (2017-2022)
11.11.5 LEO Pharma Recent Development
11.12 Biogen
11.12.1 Biogen Company Detail
11.12.2 Biogen Business Overview
11.12.3 Biogen Psoriasis Treatment Drugs Introduction
11.12.4 Biogen Revenue in Psoriasis Treatment Drugs Business (2017-2022)
11.12.5 Biogen Recent Development
11.13 Galectin Therapeutics
11.13.1 Galectin Therapeutics Company Detail
11.13.2 Galectin Therapeutics Business Overview
11.13.3 Galectin Therapeutics Psoriasis Treatment Drugs Introduction
11.13.4 Galectin Therapeutics Revenue in Psoriasis Treatment Drugs Business (2017-2022)
11.13.5 Galectin Therapeutics Recent Development
11.14 Cellceutix
11.14.1 Cellceutix Company Detail
11.14.2 Cellceutix Business Overview
11.14.3 Cellceutix Psoriasis Treatment Drugs Introduction
11.14.4 Cellceutix Revenue in Psoriasis Treatment Drugs Business (2017-2022)
11.14.5 Cellceutix Recent Development
11.15 Bayer
11.15.1 Bayer Company Detail
11.15.2 Bayer Business Overview
11.15.3 Bayer Psoriasis Treatment Drugs Introduction
11.15.4 Bayer Revenue in Psoriasis Treatment Drugs Business (2017-2022)
11.15.5 Bayer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
